Table 4 Most commonly prescribed and non-prescribed (including over the counter and other) drugs used by FRDA respondents in the UK
From: Impact of Friedreich’s Ataxia on health-care resource utilization in the United Kingdom and Germany
Prescription drugs (n=37)1 | Non-prescribed medication (n=14)1 | |
|---|---|---|
n (%) | n (%) | |
Idebenone | 10 (27%) | 2 (14%) |
Co-enzyme Q10 | 9 (24%) | 8 (57%) |
Vitamin E | 10 (27%) | 7 (50%) |
Beta-adrenoreceptor blocking agents (Atenolol, Bisoprolol, Propranolol) | 9 (24%) | 0 |
Skeletal muscle relaxants | 7 (19%) | 0 |
Anti-epileptic drugs | 6 (16%) | 0 |
Fish oils (Omega 3 fatty acids) | 0 | 4 (28%) |
Other nutritional supplements (Multivitamins, minerals etc) | 0 | 7 (50%) |